Skip to main content
. Author manuscript; available in PMC: 2010 Apr 12.
Published in final edited form as: Future Med Chem. 2009 Apr;1(1):95–118. doi: 10.4155/fmc.09.6

Table 4.

Tetrasaccharides.

graphic file with name nihms-133110-f0006.jpg

Study Compound Assays* Activity Lit. no.‡ Ref.
Chakraborty (2006) IG-35 Lipogenesis Inactive 3 [73]
Chakraborty (2006) IG-36 Lipogenesis Inactive 4 [73]
Chakraborty (2005) IG-37 Lipogenesis 63% MIR, EC50 = 10.6 μM 3α [49]
Chakraborty (2005) IG-38 Lipogenesis 51% MIR, EC50 = 9.8 μM 3β [49]
Chakraborty (2005) IG-39 Lipogenesis 78% MIR, EC50 = 1.1 μM 4α [49]
Chakraborty (2005) IG-40 Lipogenesis 47% MIR, EC50 = 9.5 μM 4β [49]
*

Details of assays (in alphabetical order) are given in the text.

‡

The number assigned to this compound in the cited publication.

Lit. no.: Literacy number; MIR: Maximal insulin response.